US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 1.7600
  • +0.0200+1.15%
Close May 14 16:00 ET
  • 1.7800
  • +0.0200+1.14%
Post 17:08 ET
1.03BMarket Cap-10352P/E (TTM)

Perspective Therapeutics Key Stats

Perspective Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 15, 2024

Revenue(YoY)

68.80K

-95.99%
EPS(YoY)

-0.03

+6.69%

Strong Buy

May 14, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 70.200K--
May 15, 20242024/Q1-- / 68.800K--
--2023/Q4-4.902M / 2.122M--
--2023/Q31.909M / 2.200M--
--2023/Q22.088M / 2.610M--
Nov 10, 20222023/Q11.717M / 3.135M--
Sep 28, 20222022/Q42.505M / 2.844M--
May 10, 20222022/Q32.910M / 3.000M--
Feb 8, 20222022/Q22.816M / 2.800M--
Nov 10, 20212022/Q12.564M / 2.500M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 70.200K--
May 15, 20242024/Q1-- / 68.800K--
--2023/Q4-4.902M / 2.122M--
--2023/Q31.909M / 2.200M--
--2023/Q22.088M / 2.610M--
Nov 10, 20222023/Q11.717M / 3.135M--
Sep 28, 20222022/Q42.505M / 2.844M--
May 10, 20222022/Q32.910M / 3.000M--
Feb 8, 20222022/Q22.816M / 2.800M--
Nov 10, 20212022/Q12.564M / 2.500M--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 14, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg